Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124510 | SCV000167943 | benign | not specified | 2012-11-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001080649 | SCV000262272 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588807 | SCV000696672 | benign | not provided | 2017-03-15 | criteria provided, single submitter | clinical testing | Variant summary: The COL5A2 c.3411C>T (p.Gly1137Gly) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. 5/5 splice prediction tools suggest that this change eliminates a cryptic donor cite. ESE finder predicts that this variant may create an SF2/ASF ESE site at the locus. However, these predictions have yet to be confirmed by functional studies. This variant was found in 115667/121246 control chromosomes (55328 homozygotes) at a frequency of 0.9539861, which is approximately 763188 times the estimated maximal expected allele frequency of a pathogenic COL5A2 variant (0.0000013), suggesting that "C" allele is an ancestral allele. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. |